Oncology Revenue Cycle Management
Oncology billing built for infusion suites and radiation practices
Medbilling RCM provides oncology medical billing: chemotherapy infusion hierarchy coding, J-code drug billing with JW/JZ compliance, NDC conversions, radiation treatment management, and biologic prior authorization for medical oncology, radiation oncology, and hematology practices across all 50 states. A single encounter generates five billing categories from one chair.
5-day onboarding · All 50 states
Where oncology billing breaks
Four revenue leaks hiding inside your oncology billing
Oncology combines drug billing, infusion billing, and physician billing in a single encounter. Each component carries its own rules, and on high-cost biologics a single error costs thousands.
Infusion hierarchy billed out of order
Chemotherapy billing starts with a strict rule: only one initial code per encounter. Chemotherapy ranks first (96413), therapeutic infusion second (96365), hydration third (96360). Bill two initial codes in the same tier and the payer auto-bundles both. We've seen practices billing 96413 as the initial on every chair without sequencing the add-ons correctly, losing sequential revenue on every multi-drug visit.
JW/JZ modifiers missing on drug claims
Since January 2024, every single-dose vial claim must carry either JW (drug wastage documented) or JZ (zero waste). Skip both and Medicare returns the claim as unprocessable. On a $3,000 biologic vial, that's $3,000 sitting in limbo until someone catches it. Scale that across 20 infusion chairs running five days a week and it won't stop compounding.
NDC unit conversions filed incorrectly
A drug's HCPCS code defines billing units per milligram. If J9271 (pembrolizumab) is 1 mg per unit and the patient gets 200 mg, the claim needs 200 units -- not 1, not 2. And the 10-digit NDC on the vial has to be converted to an 11-digit 5-4-2 format before the clearinghouse accepts it.
Radiation billing bundled across phases
Radiation oncology billing runs through planning (77263), simulation, physics (77300/77301), device fabrication (77334), and delivery (77373/77385). Weekly management (77427) is billed per 5 delivered fractions, not per calendar week. If a patient finishes with 3 or 4 remaining fractions, those are billable as one unit. If you don't catch the count and revenue stays on the table.
The Oncology Billing Gap
Five-Phase Operating System
How the Revenue Control Framework runs for oncology practices
Oncology doesn't break on code selection alone. It breaks on drug math -- unit conversions that don't match the vial, NDC formats the clearinghouse rejects, and wastage modifiers that never got appended. The framework is our oncology revenue cycle management system, and it catches all of it before claims ship.
Financial clearance and prior authorization
Insurance verification first: coverage, deductibles, secondary plans confirmed before treatment. For high-cost biologics and immunotherapy, we build the PA package with clinical documentation, genomic results, and treatment protocol. We track approval expiration dates so no infusion starts without active authorization. Providers needing enrollment go through our medical credentialing team.
Flowsheet scrubbing and chair-time capture
Our coders review nursing infusion flowsheets inside your EHR. Start times, stop times, IV access sites, push techniques, and hydration protocols -- all verified before we'll start coding. Oncology's biologic infusion overlap with rheumatology is significant, and we handle the same hierarchy logic and JW/JZ compliance across both.
J-code, NDC, and modifier coding
J-code billing starts here. We assign exact HCPCS codes, convert manufacturer NDCs into 11-digit 5-4-2 format, and calculate precise billing unit multipliers per vial. JW goes on the wastage line. JZ goes on the administered line when nothing was discarded. Infusion hierarchy gets sequenced correctly: one initial, the rest as add-ons. Our medical coding team handles the complexity.
Denial resolution and AR recovery
A payer denies a J9271 claim. Was it CO-16 (missing NDC) or CO-197 (expired pre-auth)? Big difference. CO-16 is a resubmission with the NDC corrected. CO-197 requires a retroactive auth appeal. We classify every denial by CARC/RARC code and fix the root cause. Our AR recovery team works 30/60/90+ day receivables.
Payment posting and margin reporting
Every ERA gets reconciled against your contracted rates and ASP payment allowances. If a payer underpaid a J9299 (nivolumab) claim against the current quarter's ASP file, we catch it. Monthly dashboards track drug margin velocity, denial rate by J-code, and revenue by modality.
oncology-billing-workflow.webp
560 × 500px · WebP
Oncology billing specialist reviewing J-code drug billing dashboard on dual monitors showing infusion hierarchy coding queue, NDC unit validation, and JW/JZ compliance tracker inside Flatiron OncoEMR or Epic Beacon. Professional billing office, warm lighting, no patient data. Documentary photography.
Oncology Coding Reference
Treatment codes and modifiers we bill every encounter
Our oncology coding services cover every code across medical, radiation, and surgical oncology, verified against AMA CPT 2026.
oncology-coding-dashboard.webp
1180 × 340px · WebP (wide)
Wide banner showing oncology billing dashboard with J-code infusion hierarchy sequencer, NDC 5-4-2 converter, JW/JZ modifier compliance tracker, radiation fraction counter (77427), and PA expiration calendar. Professional oncology billing office. Wide landscape documentary style.
| Category | CPT/HCPCS | Billing notes |
|---|---|---|
| Chemo infusion admin | 96413, +96415, +96417, 96409/+96411 | One initial per encounter. Hierarchy: chemo > therapeutic > hydration. |
| Therapeutic/supportive | 96365, +96367, 96374/+96375, 96360/+96361 | Pre-meds billed as sequential (+96367) or push (+96375), never initial. |
| High-cost J-codes | J9271, J9299, J9035, J9312, J1442 | 11-digit NDC (5-4-2). JW for waste, JZ for zero. Unit = dose / descriptor. |
| Radiation oncology | 77263, 77301, 77334, 77373, 77427 | 77427 per 5 delivered fractions. 77301 bundles 77300 same day. |
| Hematology | 38220, 38221, 38222 | Bill 38222 for combined aspiration + biopsy. Don't unbundle. |
| Clinical trials | Mod Q0, Mod Q1, ICD-10 Z00.6 | Q1 for routine costs. Q0 for investigational. NCT in Box 19. |
| Key modifiers | JW, JZ, Mod 25, Mod 59/X{EPSU}, TC/26 | JW/JZ mandatory on every single-dose container since Jan 2024. |
Oncology Denial Patterns
Four denial codes that cost oncology practices the most
These four codes, verified against the NCCI Policy Manual, drive the bulk of oncology claim denials.
The most common oncology denial, driven by missing or incomplete claim data such as a missing 11-digit NDC, incorrect drug units, or an absent JW/JZ modifier
Validate NDC 5-4-2 format and append JW or JZ before submission
Frequently triggered by complex drug and radiation prior authorization requirements, including pre-auth missing or expired on chemo, biologic, or immunotherapy
Track auth expiration dates and rebuild PA before treatment starts
Common in infusion bundling and multi-code radiation sessions, including an infusion hierarchy error with two initial codes billed in the same encounter
Sequence by tier: chemo initial, everything else as add-on
Often seen with chemotherapy administration and drug waste modifiers, including a drug admin modifier error or TC/26 component split filed incorrectly
Verify modifier placement and component routing per payer
CO-16 is the most expensive oncology denial because it hits the drug claim directly. As an oncology billing company, we onboarded an infusion suite billing 96413 as the initial on every chair without sequencing add-ons. A significant volume of weekly encounters were losing sequential revenue due to missed charge capture and incorrect sequencing. We restructured the hierarchy mapping and configured X12 CARC definitions tracking in week one.
Division of Work
What your team handles versus what our team handles
We don't replace your nurses or physicians. We plug into your workflow and handle the billing.
Oncology EHR and OIS Compatibility
Works with the oncology systems your practice runs
Your EHR and OIS stay in place. We connect and run parallel during transitions.
Get a Free Revenue Assessmentoncology-ois-system.webp
600 × 520px · WebP
Oncology billing coordinator at dual monitors showing Flatiron OncoEMR or Varian ARIA OIS interface with infusion treatment plan, J-code drug billing queue, and PA tracking by drug. Professional oncology billing office, warm lighting, no patient data. Documentary style.
Common Questions
What oncology practices ask before switching billing partners
Straight answers about infusion hierarchy, drug billing, radiation coding, and pricing.
How does the chemotherapy infusion hierarchy work?
Only one initial code is reported per encounter, and it goes to the highest-tier service. Chemotherapy (96413) outranks therapeutic infusion (96365), which outranks hydration (96360). Everything after the initial is billed as a sequential or concurrent add-on. Two initial codes in the same tier is an automatic bundling denial.
What's the difference between JW and JZ modifiers?
Modifier JW goes on a separate claim line for the exact units discarded from a single-dose vial. JZ goes on the administered drug line when the full vial was used with nothing discarded. Since January 2024, every single-dose vial claim must carry one or the other. Skip both and the claim won't process.
How do you prevent underpayments on high-cost drug claims?
Most underpayments come from unit conversion errors. If J9271 (pembrolizumab) is defined as 1 mg per unit and the patient receives 200 mg, the claim needs 200 units. We verify every NDC against the dose, convert to 5-4-2 format, and cross-reference the quarter's ASP file.
How is radiation treatment management (77427) billed?
CPT 77427 is reported once per 5 delivered fractions, regardless of calendar weeks. Fractions carry over until a cluster of 5 is complete. At end of course, a remaining count of 3 or 4 fractions can be billed as one unit. Counts of 1 or 2 can't be billed separately.
How do you protect buy-and-bill drug margins?
We track wholesale acquisition cost against the current quarter's ASP reimbursement allowance. Medicare pays ASP plus 6%, reduced to effectively 4.3% after sequestration. If a payer underpays against ASP, we catch it at posting and file an appeal. Our physician billing team handles the professional component.
What does onboarding look like for an oncology practice?
We start with EHR/OIS access, your payer contracts, and your current infusion flowsheet workflow. Within the first few days, we configure J-code unit tables, NDC conversion rules, JW/JZ compliance checks, and PA tracking by drug. Most practices are fully transitioned in 5 business days.
Ready when you are
Our oncology medical billing services assessment is built for your practice
We'll pull a sample of your claims and show your infusion hierarchy accuracy, JW/JZ compliance rate, drug margin by J-code, and denial rate by modality.
- Infusion hierarchy accuracy: one initial per encounter, add-ons sequenced correctly
- JW/JZ compliance rate: every single-dose vial claim audited for modifier presence
- NDC unit validation: 11-digit 5-4-2 format and dose-to-unit calculation per drug
- Drug margin review: ASP reimbursement vs contracted rates per J-code
- PA tracking audit: authorization expiration dates by drug and payer
- No setup fees. No long-term contract.
Get a Free Revenue Assessment
Sources: CMS HCPCS J-code tables; CMS NDC 5-4-2 rules; AMA CPT 2026; X12 CARC (2026); NCCI Policy Manual; AMA 2024 Prior Authorization Physician Survey; MGMA; HFMA.